UVA Engineering (@uvaengineers) 's Twitter Profile
UVA Engineering

@uvaengineers

University of Virginia School of Engineering and Applied Science

ID: 30226467

linkhttp://engineering.virginia.edu/ calendar_today10-04-2009 14:33:04

5,5K Tweet

6,6K Takipçi

1,1K Takip Edilen

UVA Engineering (@uvaengineers) 's Twitter Profile Photo

Tempo Therapeutics, founded by BME & CHE associate professor Donald Griffin, recently dosed the first patients in their TT101 trial. TT101 is a solution designed to regrow large volumes of tissue while preventing disfiguring scars for skin cancer patients. Bill Epling @uvabme

Tempo Therapeutics, founded by BME & CHE associate professor Donald Griffin, recently dosed the first patients in their TT101 trial. TT101 is a solution designed to regrow large volumes of tissue while preventing disfiguring scars for skin cancer patients. 
<a href="/uvachechair/">Bill Epling</a>  @uvabme